Patent Assignment
Reel/Frame 074388/0924
Security Interest
Recorded: 2026-04-16
Pages: 4
Assignor
EMERGENT BIOSOLUTIONS CANADA INC.
Executed: 2026-04-16
Assignee
ORBIMED ROYALTY & CREDIT OPPORTUNITIES V, LP, AS ADMINISTRAT
601 LEXINGTON AVENUE 54TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Property
(1)
Hyperimmune Globulin Formulations
Application:
18/246,373 →
Publication:
US 2024/0052020
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Notice of Grant of Security Interest in U.S. Patents
Sep 3, 2024
From: EMERGENT BIODEFENSE OPERATIONS LANSING LLC; EMERGENT BIOSOLUTIONS CANADA INC.; EMERGENT BIOSOLUTIONS INC.; EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC
To: OHA AGENCY LLC
Reel/Frame 068828/0233 →
Security Interest
Sep 30, 2024
From: EMERGENT BIODEFENSE OPERATIONS LANSING LLC; EMERGENT BIOSOLUTIONS INC.; EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.; EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 068746/0698 →
Release of Security Interest
Apr 29, 2026
From: OHA AGENCY LLC, IN ITS CAPACITY AS ADMINISTRATIVE AGENT
To: EMERGENT BIOSOLUTIONS CANADA INC.
Reel/Frame 074509/0552 →